Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Aricept Moves Up to 3rd Place in Domestic Drugs Sales Ranking
January 12, 2009
- PSJ Symposium Calls on Researchers to Venture into New Fields
January 12, 2009
- Daiichi Sankyo to Report Valuation Loss of ¥354 Bil.
January 12, 2009
- R&D NEWS IN BRIEF
January 12, 2009
- Indirect Divisions to Support MRs at Novo Nordisk
January 12, 2009
- Market for Generics to Expand to ¥359.7 Bil. in 2010
January 12, 2009
- Kyowa Kirin to Transfer Neu-Up to Avoid Problems with AML
January 12, 2009
- Korosho to Educate Doctors on Benefits of Generics
January 12, 2009
- MediciNova Proposes Acquisition to Avigen
January 12, 2009
- New Management Team Members Appointed for Ranbaxy
January 12, 2009
- MTPC Transfers Shares of API to MCC
January 12, 2009
- Business Strategy for 2009 Announced by Agilent Technologies
January 12, 2009
- Novartis, Mochida Terminate Copromotion of Diovan
January 12, 2009
- RDKK Launches Titanium Series of Reagent Kits for Its Genome Sequencer FLX
January 12, 2009
- BUSINESS NEWS IN BRIEF
January 12, 2009
- GEYMS Launches New Models in Signa MRI Series
January 12, 2009
- Prasugrel to Be Reviewed in US in February
January 12, 2009
- MEDICAL DEVICE NEWS IN BRIEF
January 12, 2009
- Omalizumab, Maraviroc, Nalfurafine Recommended for Approval
January 12, 2009
- Korosho to Restrict Online Sales of Drugs to Class 3 Products
January 12, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…